Tanvex BioPharma (Taiwan) Market Value
| 6541 Stock | TWD 68.10 1.70 2.44% |
| Symbol | Tanvex |
Tanvex BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tanvex BioPharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tanvex BioPharma.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Tanvex BioPharma on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Tanvex BioPharma or generate 0.0% return on investment in Tanvex BioPharma over 30 days. Tanvex BioPharma is related to or competes with OBI Pharma, Adimmune Corp. Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of bios... More
Tanvex BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tanvex BioPharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tanvex BioPharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.93 | |||
| Information Ratio | 0.0697 | |||
| Maximum Drawdown | 15.1 | |||
| Value At Risk | (3.04) | |||
| Potential Upside | 6.22 |
Tanvex BioPharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tanvex BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tanvex BioPharma's standard deviation. In reality, there are many statistical measures that can use Tanvex BioPharma historical prices to predict the future Tanvex BioPharma's volatility.| Risk Adjusted Performance | 0.0965 | |||
| Jensen Alpha | 0.243 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.1011 | |||
| Treynor Ratio | 0.5223 |
Tanvex BioPharma Backtested Returns
Tanvex BioPharma appears to be very steady, given 3 months investment horizon. Tanvex BioPharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0759, which indicates the firm had a 0.0759% return per unit of risk over the last 3 months. We have found thirty technical indicators for Tanvex BioPharma, which you can use to evaluate the volatility of the company. Please review Tanvex BioPharma's Semi Deviation of 1.53, coefficient of variation of 859.3, and Risk Adjusted Performance of 0.0965 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tanvex BioPharma holds a performance score of 5. The entity has a beta of 0.61, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tanvex BioPharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tanvex BioPharma is expected to be smaller as well. Please check Tanvex BioPharma's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Tanvex BioPharma's existing price patterns will revert.
Auto-correlation | -0.5 |
Modest reverse predictability
Tanvex BioPharma has modest reverse predictability. Overlapping area represents the amount of predictability between Tanvex BioPharma time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tanvex BioPharma price movement. The serial correlation of -0.5 indicates that about 50.0% of current Tanvex BioPharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 7.74 |
Tanvex BioPharma lagged returns against current returns
Autocorrelation, which is Tanvex BioPharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tanvex BioPharma's stock expected returns. We can calculate the autocorrelation of Tanvex BioPharma returns to help us make a trade decision. For example, suppose you find that Tanvex BioPharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tanvex BioPharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tanvex BioPharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tanvex BioPharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tanvex BioPharma stock over time.
Current vs Lagged Prices |
| Timeline |
Tanvex BioPharma Lagged Returns
When evaluating Tanvex BioPharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tanvex BioPharma stock have on its future price. Tanvex BioPharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tanvex BioPharma autocorrelation shows the relationship between Tanvex BioPharma stock current value and its past values and can show if there is a momentum factor associated with investing in Tanvex BioPharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tanvex Stock Analysis
When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.